Trials / Unknown
UnknownNCT04772846
Chloroquine for Glioblastoma.
Adjuvant Chloroquine to the Conventional Treatment for Glioblastoma.
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Egyptian Medical Syndicate · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Adjuvant chloroquine to the conventional treatment for glioblastoma; A randomized, single-blind, placebo-controlled, phase I/II trial.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oral tablet | Oral 250mg chloroquine tablets |
| DRUG | Placebo | Oral placebo tablets |
Timeline
- Start date
- 2018-03-01
- Primary completion
- 2020-12-01
- Completion
- 2021-03-01
- First posted
- 2021-02-26
- Last updated
- 2021-02-26
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT04772846. Inclusion in this directory is not an endorsement.